Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases

Indian Journal of Medical Research

Volumn 122, Issue 4, 2005, Pages 330-337

  Manchanda, Vikas ^a   Singh, N P ^a   Goyal, R ^a   Kumar, A ^a   Thukral, S S ^b  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Double disk synergy test; ESBLs; K. pneumoniae; MIC reduction test

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KANAMYCIN; LORACARBEF; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DILUTION; HOSPITAL; INDIA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BETA-LACTAMASES; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 30744435595     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 10th Informational Supplement, Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards Document M100-S10; 2000.
2. D'Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenovar F. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital J Infect 1998; 36: 279-85.
3. Dandekar PK, Barrett NL, Nightingale CH, Nicolau DP. Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002. Conn Med 2003; 67: 149-52.
4. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
5. Thomson KS, Sanders CC. Detection of extended spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 1992; 36: 1877-82.
6. Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the E test ESBL screen. J Clin Microbiol 1996; 34: 1880-4.
7. Bradford PA. Extended spectrum beta-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
8. MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV- derived extended - spectrum beta-lactamase detection. Clin Microbiol Infect 2002; 8: 715-24.
9. Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003; 51: 415-8.
10. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; 421-5.
11. Subha A, Ananthan S. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20: 92-5.
12. Ananthakrishanan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta-lactamase producers among surgical wound infectons and burns patiens in JIPMER. Indian J Med Microbiol 2000; 18: 160-5.
13. Hansotia JB, Agarwal V, Pathak AA, Saoji A M. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105: 158-61.
14. Abigail S, Mathai E, Jesudason MV, John TJ. Ceftazidime resistance among Klebsiella pneumoniae in south India Indian J Med Res 1995; 102: 53-5.
15. Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary care hospital Indian J Med Microbiol 2004; 22: 87-91.
16. Revathi G, Singh S, Singh S. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997; 15: 113-5.
17. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115: 153-7.
18. Khurana S, Taneja N, Sharma M. Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002; 116: 145-9.
19. Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test J Antimicrob Chemother 2004; 54: 684-7.
20. Crichton PB. Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In: Collee, I G, Fraser A G, Marmion, B P, Simmons A, editors. Mackie & McCartney practical medical microbiology, 14th ed. Edinburgh, UK: Churchill Livingstone, 1996; p. 361-84.
21. Jorgensen JH, Turnidge JD. Susceptibility testing methods: Dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Jorgenson JH, Yolken RH, editors. Manual of clinical microbiology, 8th ed VA, USA: ASM Press 2003; p. 1108-27.
22. West PW. Extended spectrum beta-lactamase producing Klebsiella spp. Br J Biomed Sci 2000; 57: 226-33.
23. Yuan M, Aucken H, Hall LM, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother 1998; 41: 527-39.
24. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 2061-7.
25. Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a Veterans medical center: seek and you may find. J Clin Microbiol 1997; 35: 2593-7.
26. Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor-potentiated disk-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1998; 42: 49-54.
27. Kocazeybek BS. Antimicrobial resistance surveillance of Gram-negative isolated from intensive care units of four different hospitals in Turkey. Evaluation of the prevalence of extended-spectrum and inducible beta-lactamases using different E-test strips and direct induction methods. Chemotherapy 2001; 47: 396-408.